| Title |
Blood pressure lowering efficacy of potassium‐sparing diuretics (that block the epithelial sodium channel) for primary hypertension
|
|---|---|
| Published in |
Cochrane database of systematic reviews, November 2012
|
| DOI | 10.1002/14651858.cd008167.pub3 |
| Pubmed ID | |
| Authors |
Balraj S Heran, Jenny MH Chen, Josh J Wang, James M Wright |
| Abstract |
Potassium-sparing diuretics, which block the epithelial sodium channel (ENaC), are widely prescribed for hypertension as a second-line drug in patients taking other diuretics (e.g. thiazide diuretics) and much less commonly prescribed as monotherapy. Therefore, it is essential to determine the effects of ENaC blockers on blood pressure (BP), heart rate and withdrawals due to adverse effects (WDAEs) when given as a first-line or second-line therapy. |
Mendeley readers
The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 92 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 20 | 22% |
| Researcher | 10 | 11% |
| Student > Bachelor | 9 | 10% |
| Student > Ph. D. Student | 7 | 8% |
| Professor | 6 | 7% |
| Other | 19 | 21% |
| Unknown | 21 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 37 | 40% |
| Nursing and Health Professions | 8 | 9% |
| Agricultural and Biological Sciences | 5 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
| Biochemistry, Genetics and Molecular Biology | 4 | 4% |
| Other | 10 | 11% |
| Unknown | 24 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 June 2023.
All research outputs
#7,387,249
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#8,415
of 11,499 outputs
Outputs of similar age
#53,193
of 192,725 outputs
Outputs of similar age from Cochrane database of systematic reviews
#170
of 240 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,725 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 240 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.